A constraint-based modelling approach to metabolic dysfunction in Parkinson's disease

[1]  H Bratzke,et al.  Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. , 1998, Progress in brain research.

[2]  D. Berg,et al.  Brain iron pathways and their relevance to Parkinson's disease. , 2001, Journal of neurochemistry.

[3]  E. Blaak,et al.  Gender differences in fat metabolism , 2001, Current opinion in clinical nutrition and metabolic care.

[4]  H. Qian,et al.  Energy balance for analysis of complex metabolic networks. , 2002, Biophysical journal.

[5]  A. Burgard,et al.  Optimization-based framework for inferring and testing hypothesized metabolic objective functions. , 2003, Biotechnology and bioengineering.

[6]  Lorene M Nelson,et al.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. , 2003, American journal of epidemiology.

[7]  M. Vila,et al.  COX‐2 and Neurodegeneration in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[8]  A. Messac,et al.  The normalized normal constraint method for generating the Pareto frontier , 2003 .

[9]  P. Karp,et al.  Computational prediction of human metabolic pathways from the complete human genome , 2004, Genome Biology.

[10]  L. Tretter,et al.  Initiation of Neuronal Damage by Complex I Deficiency and Oxidative Stress in Parkinson's Disease , 2004, Neurochemical Research.

[11]  J. Rinn,et al.  Major molecular differences between mammalian sexes are involved in drug metabolism and renal function. , 2004, Developmental cell.

[12]  P. Mcgeer,et al.  Inflammation and neurodegeneration in Parkinson's disease. , 2004, Parkinsonism & related disorders.

[13]  G. Wooten,et al.  Are men at greater risk for Parkinson’s disease than women? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  Rotterdam.  Incidence of parkinsonism and Parkinson disease in a general population: The Rot terdam Study , 2005 .

[15]  H. Qian,et al.  Thermodynamics of stoichiometric biochemical networks in living systems far from equilibrium. , 2005, Biophysical chemistry.

[16]  Ian R. Lanza,et al.  Sex differences in glycolysis during brief, intense isometric contractions , 2005, Muscle & nerve.

[17]  H. Qian,et al.  Thermodynamic-based computational profiling of cellular regulatory control in hepatocyte metabolism. , 2005, American journal of physiology. Endocrinology and metabolism.

[18]  H. Przuntek,et al.  Parenteral application of NADH in Parkinson's disease: Clinical improvement partially due to stimulation of endogenous levodopa biosynthesis , 2005, Journal of Neural Transmission.

[19]  Stephen P. Boyd,et al.  Convex Optimization , 2004, Algorithms and Theory of Computation Handbook.

[20]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[21]  B. Palsson.  Systems Biology: Properties of Reconstructed Networks , 2006 .

[22]  Bastiaan R Bloem,et al.  Gender differences in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[24]  W. Ying.  NAD+ and NADH in brain functions, brain diseases and brain aging. , 2007, Frontiers in bioscience : a journal and virtual library.

[25]  K. Ülgen,et al.  Reconstruction and flux analysis of coupling between metabolic pathways of astrocytes and neurons: application to cerebral hypoxia , 2007, Theoretical Biology and Medical Modelling.

[26]  E. Hirsch,et al.  Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.

[27]  M. Tansey,et al.  Neuroinflammation in Parkinson’s Disease , 2009, Journal of Neuroimmune Pharmacology.

[28]  Eberhard O Voit,et al.  Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals , 2009, Synapse.

[29]  SnapShot: Pathogenesis of Parkinson's Disease , 2009, Cell.

[30]  B. Palsson,et al.  A protocol for generating a high-quality genome-scale metabolic reconstruction , 2010 .

[31]  P. Mali,et al.  Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions , 2010, Stem cells.

[32]  B. Palsson,et al.  Large-scale in silico modeling of metabolic interactions between cell types in the human brain , 2010, Nature Biotechnology.

[33]  Mathieu Cloutier,et al.  An energy systems approach to Parkinson's disease , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[34]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[35]  Antje Chang,et al.  BRENDA, the enzyme information system in 2011 , 2010, Nucleic Acids Res..

[36]  Ying Sun,et al.  Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.

[37]  P. Wellstead,et al.  Systems Biology of Parkinson's Disease , 2012, Springer New York.

[38]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[39]  Ronan M. T. Fleming,et al.  A variational principle for computing nonequilibrium fluxes and potentials in genome-scale biochemical networks. , 2011, Journal of theoretical biology.

[40]  J. Silberg,et al.  A transposase strategy for creating libraries of circularly permuted proteins , 2012, Nucleic acids research.

[41]  R. McIntyre,et al.  Crosstalk between metabolic and neuropsychiatric disorders , 2012, F1000 biology reports.

[42]  P. Wellstead,et al.  Dynamic modelling of protein and oxidative metabolisms simulates the pathogenesis of Parkinson's disease. , 2012, IET systems biology.

[43]  The UniProt Consortium,et al.  Reorganizing the protein space at the Universal Protein Resource (UniProt) , 2011, Nucleic Acids Res..

[44]  Costas D. Maranas,et al.  OptCom: A Multi-Level Optimization Framework for the Metabolic Modeling and Analysis of Microbial Communities , 2012, PLoS Comput. Biol..

[45]  Feng Q. He,et al.  The role of regulatory T cells in neurodegenerative diseases , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

[46]  M. Schwartz,et al.  How Do Immune Cells Support and Shape the Brain in Health, Disease, and Aging? , 2013, The Journal of Neuroscience.

[47]  G. Donmez,et al.  SIRT1 and SIRT2: emerging targets in neurodegeneration , 2013, EMBO molecular medicine.

[48]  H. Shimizu,et al.  Flux analysis and metabolomics for systematic metabolic engineering of microorganisms. , 2013, Biotechnology advances.

[49]  D. Surmeier,et al.  Neuronal vulnerability, pathogenesis, and Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[50]  J. Paul Bolam,et al.  The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease , 2013, Front. Comput. Neurosci..

[51]  Andreas Zell,et al.  Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein , 2013, BMC Neuroscience.

[52]  Y. Nolan,et al.  Parkinson's disease in the nuclear age of neuroinflammation. , 2013, Trends in molecular medicine.

[53]  E. Katunina,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[54]  D. Surmeier,et al.  Neuronal vulnerability, pathogenesis, and Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[55]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[56]  José Castillo,et al.  Equispaced Pareto front construction for constrained bi-objective optimization , 2013, Math. Comput. Model..

[57]  C. Maranas,et al.  Recent advances in the reconstruction of metabolic models and integration of omics data. , 2014, Current opinion in biotechnology.

[58]  Nikos Vlassis,et al.  Fast Reconstruction of Compact Context-Specific Metabolic Network Models , 2013, PLoS Comput. Biol..

[59]  Zoran Nikoloski,et al.  Generalized framework for context-specific metabolic model extraction methods , 2014, Front. Plant Sci..

[60]  Costas D. Maranas,et al.  k-OptForce: Integrating Kinetics with Flux Balance Analysis for Strain Design , 2014, PLoS Comput. Biol..

[61]  Jennifer L Reed,et al.  Software platforms to facilitate reconstructing genome-scale metabolic networks. , 2014, Environmental microbiology.

[62]  Longfei Mao,et al.  Computational comparison of mediated current generation capacity of Chlamydomonas reinhardtii in photosynthetic and respiratory growth modes. , 2014, Journal of bioscience and bioengineering.

[63]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[64]  Ronan M. T. Fleming,et al.  Prediction of intracellular metabolic states from extracellular metabolomic data , 2014, Metabolomics.

[65]  Wynand S. Verwoerd,et al.  ORCA: a COBRA toolbox extension for model-driven discovery and analysis , 2014, Bioinform..

[66]  K. Ülgen,et al.  Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network , 2014, FEBS open bio.

[67]  Longfei Mao,et al.  Theoretical exploration of optimal metabolic flux distributions for extracellular electron transfer by Shewanella oneidensis MR-1 , 2014, Biotechnology for Biofuels.

[68]  E. Pekkonen,et al.  Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.

[69]  H. Wood.  Parkinson disease: Gut reactions—can changes in the intestinal microbiome provide new insights into Parkinson disease? , 2015, Nature Reviews Neurology.

[70]  J. Schiemann,et al.  Dopamine midbrain neurons in health and Parkinson’s disease: Emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels , 2015, Neuroscience.

[71]  S. Cuzzocrea,et al.  Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease. , 2015, CNS & neurological disorders drug targets.